Literature DB >> 11162621

Requirement of intact disulfide bonds in orexin-A-induced stimulation of gastric acid secretion that is mediated by OX1 receptor activation.

T Okumura1, S Takeuchi, W Motomura, H Yamada, S Egashira Si, S Asahi, A Kanatani, M Ihara, Y Kohgo.   

Abstract

Orexin-A is a neuropeptide consisting of 33 amino acids with two intrachain disulfide bonds, namely Cys6-Cys12 and Cys7-Cys14, and is a potent stimulator of food consumption and gastric acid secretion. In contrast, orexin-B, a peptide containing 28 amino acids without disulfide bond, which has no stimulatory action of gastric acid. The objective of the present study was to characterize the receptor-mediated mechanism of orexin-A-induced stimulation of gastric acid secretion using orexin-A-related peptides with modification of disulfide bonds. Intracisternal injection of orexin-A, but not orexin-B or orexin-A (15-33), that does not contain both disulfide bonds stimulated gastric acid secretion in pylorus-ligated conscious rats. The ability of the stimulation of gastric acid output was less in three alanine-substituted orexin-A, [Ala(6,12)]orexin-A, [Ala(7,14)]orexin-A, and [Ala(6,7,12,14)]orexin-A, than orexin-A. Orexins-induced calcium increase was measured in CHO-K1 cells expressing OX1R or OX2R. Orexin-A induced a transient increase in [Ca(2+)]i in CHO-K1/OX1R cells in a dose-dependent manner. EC50 values for OX1R of orexin-A, orexin-B, or orexin-A (15-33) was 0.068, 0.69 or 4.1 nM, respectively, suggesting that peptides containing no disulfide bonds have lower potency for the receptor. Agonistic activity for OX1R of the three orexin-A analogues with modification of one or both disulfide bonds was significantly reduced as compared with that of orexin-A. EC50 values for OX2R of orexin-A and orexin-B was almost equal but potency for the receptor of orexin-A (15-33) and three alanine substituted orexin-A was less than that of orexin-A. A significant inverse relationship between gastric acid output and EC50 values for OX1R, but not OX2R, was observed. These results suggested that the orexin-A-induced acid stimulation requires OX1R activation and that disulfide bonds in orexin-A may have a key role in the receptor activation. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11162621     DOI: 10.1006/bbrc.2001.4235

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  8 in total

1.  C4ORF48, a gene from the Wolf-Hirschhorn syndrome critical region, encodes a putative neuropeptide and is expressed during neocortex and cerebellar development.

Authors:  Sabine Endele; Claudia Nelkenbrecher; Annegret Bördlein; Stefanie Schlickum; Andreas Winterpacht
Journal:  Neurogenetics       Date:  2011-02-02       Impact factor: 2.660

2.  Intracisternal injection of orexin-A prevents ethanol-induced gastric mucosal damage in rats.

Authors:  Hiroto Yamada; Satoshi Tanno; Kaoru Takakusaki; Toshikatsu Okumura
Journal:  J Gastroenterol       Date:  2007-05-25       Impact factor: 7.527

Review 3.  Role of orexin in central regulation of gastrointestinal functions.

Authors:  Toshikatsu Okumura; Kaoru Takakusaki
Journal:  J Gastroenterol       Date:  2008-09-20       Impact factor: 7.527

4.  Endogenous orexin-A in the brain mediates 2-deoxy-D-glucose-induced stimulation of gastric motility in freely moving conscious rats.

Authors:  Tsukasa Nozu; Yoshihiro Tuchiya; Shima Kumei; Kaoru Takakusaki; Koji Ataka; Mineko Fujimiya; Toshikatsu Okumura
Journal:  J Gastroenterol       Date:  2011-12-15       Impact factor: 7.527

5.  Orexin receptors in GtoPdb v.2021.3.

Authors:  Paul Coleman; Luis de Lecea; Anthony Gotter; Jim Hagan; Daniel Hoyer; Thomas Kilduff; Jyrki P Kukkonen; Rod Porter; John Renger; Jerome M Siegel; Gregor Sutcliffe; Neil Upton; Christopher J Winrow
Journal:  IUPHAR BPS Guide Pharm CITE       Date:  2021-09-02

6.  Effect of orexin-a on ischemia-reperfusion-induced gastric damage in rats.

Authors:  Mehmet Bülbül; Ruken Tan; Burcu Gemici; Gözde Ongüt; V Nimet Izgüt-Uysal
Journal:  J Gastroenterol       Date:  2008-03-29       Impact factor: 7.527

7.  Hypocretin administration as a treatment for human narcolepsy.

Authors:  J M Siegel
Journal:  Sleep       Date:  2003-12-15       Impact factor: 6.313

8.  Orexin-A Excites Airway Vagal Preganglionic Neurons via Activation of Orexin Receptor Type 1 and Type 2 in Rats.

Authors:  Yonghua Chen; Yuhong Guo; Xianxia Yan; Ming Zeng; Hong Chen; Dongying Qiu; Jijiang Wang
Journal:  Front Cell Neurosci       Date:  2019-10-23       Impact factor: 5.505

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.